Analysis of Specialty Drug Out-of-Pocket Costs Tops SPT Week in Review

5. FDA OKs First Therapy Indicated for Rare Blood Clotting Disorder

Caplacizumab-yhdp (Cablivi, Sanofi) is a targeted treatment designed to inhibit the formation of blood clots in adults with acquired thrombotic thrombocytopenic purpura. Read more.

4. Abuse-Deterrent Formulation of OxyContin Linked to Surge in Hepatitis C Infection

Injection drug use has been identified as a predominant risk factor for hepatitis C infection and the opioid epidemic has been suggested as a driver of a recent rise in infections. Read more.
 
3. HHS Proposal Targets Prescription Drug Rebates in Medicare

The proposed rule aims to encourage drug manufacturers to pass discounts directly to patients and improve transparency in the market. Read more.
 
2. Emerging Trends That Could Disrupt the Status Quo in Health Care

Blockchain, mobile health, and predictive analytics are just a few areas that could improve patient care and enhance the pharmacy industry. Read more.
 
1. Specialty Drugs May Drive Higher Out-of-Pocket Costs for Medicare Patients in 2019

Medicare Part D patients can face thousands of dollars in out-of-pocket costs for a single specialty tier drug. Read more.
 



Stay up to date on the latest news in specialty pharmacy by getting Specialty Pharmacy Times in your mailbox or inbox for free!

Click here to sign up for free for the bi-monthly Specialty Pharmacy Times print journal delivered to your address.

Click here to sign up for our email newsletters delivered every Monday, Wednesday, and Friday, in addition to breaking news alerts.

Click here to follow us on Facebook. 

Click here to follow us on Twitter. 

Click here to join our LinkedIn group. 


Most Popular

Related Articles

Researchers at Brigham and Women’s Hospital set out to evaluate the effects of switching insulins in those with type 2 diabetes.
The sBLA is based on data showing significant improvement in overall survival and progression-free survival in patients with advanced renal cell carcinoma.
Top news of the day across the health care landscape.
Company Profile >
Industry Guide >
Market News >
Peer Exchange >
Conferences >
Subscribe >
Specialty Times Resources
About Us
Advertise
Careers
Contact Us
Terms & Conditions
Privacy
MJH Associates >
Pharmacy Times
OTCGuide
American Journal of Managed Care
Cure
MD Magazine
ONCLive
Targeted Oncology
Physicians' Education Resource
Pharmacy & Healthcare Communications, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright Specialty Pharmacy Times 2006-2018
Pharmacy & Healthcare Communications, LLC. All Rights Reserved.
 

$vacMongoViewPlus$